Promising Pharmaceutical Stocks To Consider - May 23rd
Read Our Latest Research Report on QBTS
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of NYSE:LLY traded down $1.83 during midday trading on Friday, reaching $713.37. The company had a trading volume of 1,689,842 shares, compared to its average volume of 3,609,122. The stock has a market capitalization of $676.08 billion, a P/E ratio of 60.92, a PEG ratio of 1.40 and a beta of 0.48. The stock’s fifty day moving average price is $791.44 and its 200-day moving average price is $803.64. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.15 and a quick ratio of 0.97. Eli Lilly and Company has a one year low of $677.09 and a one year high of $972.53.
Read Our Latest Research Report on LLY
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
TMO stock traded down $5.93 during mid-day trading on Friday, reaching $394.55. 1,418,903 shares of the stock traded hands, compared to its average volume of 2,316,934. Thermo Fisher Scientific has a 52-week low of $390.49 and a 52-week high of $627.88. The company has a current ratio of 1.66, a quick ratio of 1.29 and a debt-to-equity ratio of 0.59. The company has a market cap of $148.94 billion, a P/E ratio of 23.87, a P/E/G ratio of 2.99 and a beta of 0.82. The stock’s fifty day moving average is $445.10 and its 200-day moving average is $506.39.
